Welcome to our dedicated page for cbdMD news (Ticker: YCBD), a resource for investors and traders seeking the latest updates and insights on cbdMD stock.
cbdMD, Inc. (NYSE American: YCBD) is a premier provider of high-quality, hemp-derived cannabidiol (CBD) products. Founded in 2015 and headquartered in Charlotte, North Carolina, cbdMD has quickly become one of the most highly trusted and recognized names in the CBD industry. The company offers a broad range of CBD products under its flagship brand cbdMD, as well as its pet-focused brand Paw CBD and its newly launched ATRx Labs line of functional mushroom supplements.
The company's product portfolio includes CBD tinctures, gummies, topicals, capsules, bath bombs, bath salts, sleep aids, and veterinarian-formulated pet CBD products like tinctures, chews, and topicals. It has built a robust distribution network, leveraging its own e-commerce platform, third-party online marketplaces, wholesalers, and a variety of brick-and-mortar retailers across the United States.
In recent developments, cbdMD has introduced innovative products such as the THCV+CBG Energy Softgels, which combine the potency of two dynamic cannabinoids with caffeine and B12 to enhance energy, focus, and clarity. The company's dedication to innovation is also evident in the launch of its CBD+CBG Oil Tincture and the introduction of a new Vice President of Wholesale Sales to expand its market reach.
Financially, cbdMD has been proactive in securing funding to support its growth. Recently, the company entered a securities purchase agreement, raising $1.25 million in gross proceeds to bolster working capital and support the national rollout of its ATRx Labs functional mushroom products. Despite reporting operational losses, cbdMD has implemented cost-cutting measures and strategic initiatives aimed at achieving profitability and enhancing shareholder value.
cbdMD's latest product,
cbdMD, Inc. (NYSE American: YCBD, YCBDPA) will host a conference call on December 17, 2021, at 4:15 p.m. ET to discuss its September 30, 2021 fourth quarter and fiscal year-end financial results and business progress. The call follows a technical delay. Interested participants can join via domestic and international numbers provided. A teleconference replay will be available until January 15, 2022 and a webcast replay will be accessible until December 17, 2022.
cbdMD, Inc. (NYSE American: YCBD) has initiated a preclinical human study in collaboration with the University of South Carolina. The study aims to evaluate the effects of cbdMD’s proprietary cannabinoid blend on sleep, mood, and pain in healthy individuals, while also assessing key safety markers. The outcomes are intended to bolster the efficacy and safety profiles of cbdMD products for regulatory submissions. The company anticipates that findings from this study will facilitate future drug research and applications within its therapeutics division.
cbdMD, Inc. announced a conference call on December 16, 2021, at 4:15 p.m. Eastern Time to discuss its financial results for the fourth quarter and fiscal year ending September 30, 2021. This session will cover key business developments, and there are options for both domestic and international callers to join. The company is recognized for its extensive line of THC-free CBD products and is committed to transparency in its financial performance and future outlook.
cbdMD, Inc. (NYSE American: YCBD, YCBDpA) has appointed Dave Johnson as Senior Vice President of Business Development. With over 30 years in the consumer goods sector, including 20 years at PepsiCo (NASDAQ: PEP), Johnson will spearhead cbdMD's initiatives in expanding retail distribution across the U.S. He believes the CBD industry will experience significant growth in the next two years, positioning cbdMD to capitalize on this trend through its brands, including cbdMD and Paw CBD, and the new cbdMD Botanicals line.
cbdMD, Inc. (YCBD, YCBDPA) announced a multi-year exclusive agreement with Amify, an Amazon.com, Inc. (AMZN) partner, to launch CBD products on Amazon once the category is approved. This partnership includes cbdMD's leading products, such as gummies, tinctures, and skin care from cbdMD Botanicals. The agreement follows the growing interest in CBD since the Farm Bill's passage in 2018, positioning cbdMD to optimize its strategy for Amazon's platform. The company's Chairman emphasized readiness for market entry, enhancing cbdMD's distribution channels.
cbdMD, Inc. (NYSE: YCBD) has extended its advertising partnership with Spotify (NYSE: SPOT) and the Joe Rogan Experience (JRE) through 2022. The collaboration, which began in 2019, allows the company to tap into JRE's extensive audience, enhancing brand visibility in the CBD market. Co-CEO Martin Sumichrast emphasized the significance of this partnership, highlighting Rogan's credibility as a customer and advocate for the CBD community. cbdMD offers over 130 THC-free CBD products, contributing to its status as a leading brand in the industry.
cbdMD, Inc. (NYSE American: YCBD) will participate in the Jefferies Virtual West Coast Consumer Conference on November 16, 2021, with a fireside chat scheduled to begin at 9:50 AM ET. Investors can listen live via this link. cbdMD is a leading CBD brand, offering over 130 THC-free products including tinctures, gummies, and topicals, as well as a range of pet and beauty products. The company focuses on providing high-grade, U.S.-produced CBD solutions to consumers.
cbdMD, Inc. (NYSE American: YCBD) has appointed Matt Coapman as Chief Marketing Officer, bringing over 15 years of digital marketing and eCommerce experience. Previously, he was a Partner at Dingoz Consulting and the VP of Marketing for blu eCigs, where he significantly enhanced brand recognition. Coapman aims to drive sustainable growth, improve customer engagement, and enhance brand messaging within the CBD industry. cbdMD offers over 130 THC-free CBD products, including various SKUs for humans and pets, positioning itself as a leader in the market.
cbdMD, Inc. (NYSE American: YCBD) celebrated success at the Rogue Invitational, with athletes Justin Medeiros and Annie Thorisdottir winning gold and silver medals, respectively. The event took place in Austin, Texas, featuring top competitors in CrossFit. Medeiros praised his recovery routine post-CrossFit Games as key to his victory, while Thorisdottir expressed pride in her team's accomplishments. cbdMD's EVP of Sports Marketing, Hans Molenkamp, highlighted the athletes' achievements as inspiration, noting the brand's deep ties to the CrossFit community.
cbdMD has announced an exclusive partnership with Wodapalooza, the premier fitness festival happening from January 13-16, 2022, in Miami, Florida. As the Official CBD Partner, cbdMD will provide wellness solutions, product samples, and educational materials to athletes and gym owners. This partnership follows cbdMD's successful activation at the 2021 NOBULL CrossFit Games and aims to enhance its brand presence in the functional fitness community. The event will feature over $500k in prize money and aims to elevate the fitness community experience.
FAQ
What is the current stock price of cbdMD (YCBD)?
What is the market cap of cbdMD (YCBD)?
What does cbdMD, Inc. specialize in?
What are cbdMD's latest product innovations?
How does cbdMD distribute its products?
What recent financial steps has cbdMD taken?
What is the significance of cbdMD's ATRx Labs line?
Is cbdMD financially stable?
What challenges is cbdMD currently facing?
Where is cbdMD headquartered?
Who recently joined the cbdMD team?
What are cbdMD's future plans?
